STAT Morning Rounds: Six health news stories you need to start your day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. How sickle cell became the first CRISPR'd disease Nearly a decade…
Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.
How sickle cell became the first CRISPR’d disease
Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes. It was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company was founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first?
What's Your Reaction?
